Testing effectiveness (Phase 2)Not Yet RecruitingNCT04016129What this trial is testingCAR-T Immunotherapy Targeting CD19- ALLWho this might be right forB-cell Leukemia Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)UnknownNCT06503094What this trial is testingCD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsWho this might be right forB-Cell Lymphoblastic Leukemia/Lymphoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Early research (Phase 1)UnknownNCT05487651What this trial is testingAllogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesWho this might be right forNHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more Athenex, Inc. 36
Very early researchNot Yet RecruitingNCT07335094What this trial is testingA Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive ChemotherapyWho this might be right forB Lymphoblastic Leukemia/Lymphoma Zhujiang Hospital 60
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Early research (Phase 1)UnknownNCT05576181What this trial is testingSafety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic LeukemiaWho this might be right forAllogeneic, CAR-T, Protein Sequestration, Non-gene Edited Fundamenta Therapeutics, Ltd. 19
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Early research (Phase 1)Looking for participantsNCT06208735What this trial is testingCLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forB-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more British Columbia Cancer Agency 24
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982What this trial is testingCombination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Looking for participantsNCT05909059What this trial is testingCAR T-cell Therapy in Patients With Renal DysfunctionWho this might be right forNon-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult Northside Hospital, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT04044560What this trial is testingBlinatumomab for MRD in Pre-B ALL Patients Following Stem Cell TransplantWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaStem Cell LeukemiaMinimal Residual Disease University of British Columbia 8
Not applicableLooking for participantsNCT06785324What this trial is testingStudy of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)Who this might be right forPhiladelphia Chromosome NegativeB Cell Acute Lymphoblastic Leukemia (B-ALL)B-ALL University of Chicago 20
Testing effectiveness (Phase 2)Looking for participantsNCT02877303What this trial is testingBlinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma M.D. Anderson Cancer Center 80
Early research (Phase 1)UnknownNCT03064269What this trial is testingCAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic LeukemiaWho this might be right forB-cell Acute Lymphocytic Leukemia Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 10
Testing effectiveness (Phase 2)Ended earlyNCT00006220What this trial is testingArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Washington University School of Medicine 5
Testing effectiveness (Phase 2)WithdrawnNCT02167360What this trial is testingStudy of Efficacy and Safety of CTL019 in Adult ALL PatientsWho this might be right forB-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Active Not RecruitingNCT03233854What this trial is testingCD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell MalignanciesWho this might be right forB Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more Stanford University 56